Xponance Inc. Grows Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Xponance Inc. raised its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 1.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,269 shares of the company’s stock after buying an additional 147 shares during the period. Xponance Inc.’s holdings in HealthEquity were worth $813,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. McGlone Suttner Wealth Management Inc. purchased a new position in HealthEquity in the fourth quarter valued at $29,000. DekaBank Deutsche Girozentrale purchased a new position in HealthEquity in the third quarter valued at $41,000. Fifth Third Bancorp boosted its holdings in HealthEquity by 36.5% in the third quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock valued at $44,000 after purchasing an additional 161 shares during the period. Operose Advisors LLC purchased a new position in HealthEquity in the third quarter valued at $44,000. Finally, Covestor Ltd boosted its holdings in HealthEquity by 92.9% in the third quarter. Covestor Ltd now owns 1,119 shares of the company’s stock valued at $82,000 after purchasing an additional 539 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on HQY shares. Barrington Research reaffirmed an “outperform” rating and set a $100.00 price target on shares of HealthEquity in a report on Friday, March 22nd. JMP Securities started coverage on HealthEquity in a report on Thursday, April 4th. They set a “mkt outperform” rating and a $101.00 price target for the company. Royal Bank of Canada lifted their price target on HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, March 20th. Bank of America lifted their price target on HealthEquity from $93.00 to $97.00 and gave the stock a “buy” rating in a report on Wednesday, March 20th. Finally, JPMorgan Chase & Co. lifted their price target on HealthEquity from $86.00 to $108.00 and gave the stock an “overweight” rating in a report on Tuesday, April 2nd. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $96.17.

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 2,499 shares of the business’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $80.00, for a total value of $199,920.00. Following the transaction, the executive vice president now owns 49,996 shares in the company, valued at approximately $3,999,680. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, EVP Delano Ladd sold 2,499 shares of the stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the transaction, the executive vice president now directly owns 49,996 shares of the company’s stock, valued at approximately $3,999,680. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Jon Kessler sold 33,765 shares of the stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total value of $2,694,784.65. Following the transaction, the chief executive officer now directly owns 126,635 shares of the company’s stock, valued at $10,106,739.35. The disclosure for this sale can be found here. Insiders have sold 71,322 shares of company stock worth $5,682,895 in the last quarter. Company insiders own 2.70% of the company’s stock.

HealthEquity Stock Down 0.2 %

HQY opened at $79.04 on Friday. The business’s 50-day simple moving average is $81.08 and its 200-day simple moving average is $74.41. The company has a debt-to-equity ratio of 0.43, a quick ratio of 4.76 and a current ratio of 4.76. HealthEquity, Inc. has a one year low of $48.86 and a one year high of $84.49. The stock has a market capitalization of $6.78 billion, a P/E ratio of 123.50, a price-to-earnings-growth ratio of 1.30 and a beta of 0.53.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $0.08. The firm had revenue of $262.39 million for the quarter, compared to analysts’ expectations of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. Analysts anticipate that HealthEquity, Inc. will post 2.12 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.